Smoking Cessation
📧 Sign up to get email alerts when something new happens for Smoking Cessation.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-10-16FDA Approved: CHANTIX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for CHANTIX (varenicline tartrate) submitted by Pfizer Laboratories Div Pfizer Inc, resulting in…
-
FDA approval · 2017-09-26FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for a generic Bupropion hydrochloride product from Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: Web and Phone Intervention to Maintain Postpartum Tobacco Abstinence [NA]
A completed clinical trial evaluating a web and phone intervention to maintain postpartum tobacco abstinence.
-
CLINICAL_TRIALS trial_result · 2017-07-31Clinical Trial Update: Not Quite Ready to Quit [NA]
This is an update on a completed University of Vermont trial investigating smoking cessation; the snippet reports status but does not includ…
-
FDA approval · 2017-06-12FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Bupropion hydrochloride from Aurobindo Pharma Limited, granting generic drug status for this API…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Smoking Cessation With the Ottawa Model and SmartCard in Out-patient Respirology Clinic Setting [NA]
Clinical trial update on smoking cessation using the Ottawa Model and SmartCard in outpatient respirology settings; study status completed w…
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: Randomized Clinical Trial to Reduce Harm From Tobacco [NA]
A randomized clinical trial aimed at reducing harm from tobacco use (smoking cessation) has completed.
-
FDA approval · 2017-04-17FDA Approved: GOOD NEIGHBOR PHARMACY NICOTINE — Supplemental Application (Amerisource Bergen)
The FDA approved a supplemental application for GOOD NEIGHBOR PHARMACY NICOTINE (nicotine polacrilex), expanding its approval for this nicot…
-
FDA label_change · 2017-04-14FDA Approved: RUGBY NICOTINE POLACRILEX GUM, COATED MINT FLAVOR — Supplemental Application (Rugby Laboratories)
FDA approved a supplemental application to add a coated mint flavor to Rugby Nicotine Polacrilex Gum.
-
FDA approval · 2017-04-12FDA Approved: BUPROPION HYDROCHLORIDE (XL) — Original Application (ScieGen Pharmaceuticals,Inc.)
FDA approved ScieGen Pharmaceuticals' generic bupropion hydrochloride extended-release (XL) for the same indications as the reference produc…
-
CLINICAL_TRIALS trial_result · 2017-04-06Clinical Trial Update: A Safety and Cognitive Function Study of EVP-6124 Versus Placebo in Subjects With Nicotine Dependence [Phase 2]
Phase 2 safety and cognitive function study of encenicline (EVP-6124) versus placebo in nicotine dependence and smoking cessation was termin…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Effectiveness of the Nicotine Patch in Suppressing Nicotine Withdrawal Symptoms in Women Versus Men - 1 [Phase 2]
A Phase 2 clinical trial evaluating the nicotine patch's ability to suppress withdrawal symptoms during smoking cessation. The study compare…
-
CLINICAL_TRIALS trial_result · 2016-12-30Clinical Trial Update: Varenicline In-Patient Study [Phase 2]
A Phase 2 clinical trial update on varenicline for smoking cessation has completed, with results posted in 2016.
-
FDA approval · 2016-12-16FDA Approved: CHANTIX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for Chantix (varenicline tartrate) submitted by Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2016-08-19FDA Approved: BUPROPION HYDROCHLORIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved an original application for a generic version of bupropion hydrochloride. This expands access to the antidepressant and smoking…
-
FDA approval · 2016-08-12FDA Approved: CHANTIX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for CHANTIX (varenicline tartrate) from Pfizer, authorizing changes to the product's labeling.
-
CLINICAL_TRIALS trial_result · 2016-08-01Clinical Trial Update: A Test of Short and Long Term Naturalistic Outcomes of Smokers Who Sample Smokeless Tobacco [NA]
A completed clinical trial evaluating short- and long-term naturalistic outcomes among smokers who sample smokeless tobacco.
-
FDA approval · 2016-07-21FDA Approved: KIRKLAND SIGNATURE NICOTINE — Supplemental Application (Costco Wholesale Company)
FDA approved a supplemental application for Kirkland Signature Nicotine (nicotine polacrilex) by Costco Wholesale Company for a nicotine rep…
-
FDA approval · 2016-07-15FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Epic Pharma LLC)
FDA approved a Supplemental Application for bupropion hydrochloride (Epic Pharma LLC), signaling regulatory approval for this generic produc…
-
FDA approval · 2016-07-06FDA Approved: NICOTINE TRANSDERMAL SYSTEM — Supplemental Application (Dr. Reddys Laboratories Inc.)
FDA approved a supplemental application for the Nicotine Transdermal System (nicotine patch) from Dr. Reddy's Laboratories Inc. This action …
-
FDA approval · 2016-06-23FDA Approved: NICOTINE — Supplemental Application (Walgreen Company)
FDA approved a supplemental application for NICOTINE (nicotine polacrilex) submitted by Walgreens Company under an ANDA for the nicotine gum…
-
FDA approval · 2016-06-23FDA Approved: KIRKLAND SIGNATURE NICOTINE — Supplemental Application (Costco Wholesale Company)
FDA approved a supplemental application for Kirkland Signature Nicotine (nicotine polacrilex) submitted by Costco Wholesale Company, indicat…
-
FDA approval · 2016-06-19FDA Approved: FOSTER AND THRIVE NICOTINE — Supplemental Application (Strategic Sourcing Services LLC)
FDA approved a supplemental application for Foster and Thrive Nicotine (nicotine polacrilex) under ANDA077007, authorizing continued marketi…
-
FDA approval · 2016-05-10FDA Approved: NICOTINE TRANSDERMAL SYSTEM — Supplemental Application (Dr. Reddys Laboratories Inc.)
FDA approved a supplemental application for the nicotine transdermal system patch from Dr. Reddy's Laboratories.
-
FDA approval · 2016-03-30FDA Approved: EQUATE NICOTINE — Supplemental Application (Wal-Mart Stores Inc)
The FDA approved a supplemental application for EQUATE NICOTINE (nicotine polacrilex) from Wal-Mart Stores Inc, signaling regulatory authori…